Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   The TY3 Gag3 Spacer Controls Intracellular Condensation and Uncoating
  2. Clemens, K.; Larsen, L.; Zhang, M.; Kuznetsov, Y.; Bilanchone, V.; Randall, A.; Harned, A.; DaSilva, R.; Nagashima, K.; McPherson, A.; Baldi, P.; Sandmeyer, S.
  3. Journal of Virology. 2011, Apr; 85(7): 3055-3066.
  1. 2.   Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy
  2. McKinnon, J. E.; Delgado, R.; Pulido, F.; Shao, W.; Arribas, J. R.; Mellors, J. W.
  3. Antiviral Therapy. 2011 16(5): 725-732.
  1. 3.   Structural determinants of tobacco vein mottling virus protease substrate specificity
  2. Sun, P.; Austin, B. P.; Tozser, J.; Waugh, D. S.
  3. Protein Science. 2010, Nov; 19(11): 2240-2251.
  1. 4.   The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation
  2. Checkley, M. A.; Luttge, B. G.; Soheilian, F.; Nagashima, K.; Freed, E. O.
  3. Virology. 2010, Apr; 400(1): 137-144.
  1. 5.   Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat
  2. Adamson, C. S.; Sakalian, M.; Salzwedel, K.; Freed, E. O.
  3. Retrovirology. 2010, Apr; 7: 8.
  1. 6.   Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457)
  2. Adamson, C. S.; Waki, K.; Ablan, S. D.; Salzwedel, K.; Freed, E. O.
  3. Journal of Virology. 2009 83(10): 4884-4894.
  1. 7.   HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions
  2. Olivares, I.; Mulky, A.; Boross, P. I.; Tozser, J.; Kappes, J. C.; Lopez-Galindez, C.; Menendez-Arias, L.
  3. Journal of Molecular Biology. 2007, Sep; 372(2): 369-381.
  1. 8.   In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)
  2. Adamson, C. S.; Ablan, S. D.; Boeras, I.; Goila-Gaur, R.; Soheilian, F.; Nagashima, K.; Li, F.; Salzwedel, K.; Sakalian, M.; Wild, C. T.; Freed, E. O.
  3. Journal of Virology. 2006, Nov; 80(22): 10957-10971.
  1. 9.   Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease
  2. Feher, A.; Boross, P.; Sperka, T.; Miklossy, G.; Kadas, J.; Bagossi, P.; Oroszlan, S.; Weber, I. T.; Tozser, J.
  3. Journal of General Virology. 2006, May; 87: 1321-1330.
  1. 10.   Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase
  2. Mitchell, M. S.; Tozser, J.; Princler, G.; Lloyd, P. A.; Auth, A.; Derse, D.
  3. Journal of Biological Chemistry. 2006, FEB 17; 281(7): 3964-3971.
  1. 11.   Preliminary physical mapping of RNA-RNA linkages in the genomic RNA of Moloney murine leukemia virus
  2. Hibbert, C. S.; Rein, A.
  3. Journal of Virology. 2005, JUL; 79(13): 8142-8148.
  1. 12.   Comparison of the substrate specificity of two potyvirus proteases
  2. Tozser, J.; Tropea, J. E.; Cherry, S.; Bagossi, P.; Copeland, T.; Wlodawer, A.; Waugh, D. S.
  3. Febs Journal. 2005, JAN; 272(2): 514-523.
  1. 13.   Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli
  2. Feher, A.; Boross, P.; Sperka, T.; Oroszlan, S.; Tozser, J.
  3. Protein Expression and Purification. 2004 35(1): 62-68.
  1. 14.   In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: Effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence
  2. Tozser, J.; Shulenin, S.; Louis, J. M.; Copeland, T. D.; Oroszlan, S.
  3. Biochemistry. 2004 43(14): 4304-4312.
  1. 15.   Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase
  2. Jankowsky, J. L.; Fadale, D. J.; Anderson, J.; Xu, G. M.; Gonzales, V.; Jenkins, N. A.; Copeland, N. G.; Lee, M. K.; Younkin, L. H.; Wagner, S. L.; Younkin, S. G.; Borchelt, D. R.
  3. Human Molecular Genetics. 2004 13(2): 159-170.
  1. 16.   Effect of caspase cleavage-site phosphorylation on proteolysis
  2. Tozser, J.; Bagossi, N.; Zahuczky, G.; Specht, S. I.; Majerova, E.; Copeland, T. D.
  3. Biochemical Journal. 2003 372(Part 1): 137-143.
  1. 17.   Proteolytic events of HIV-1 replication as targets for therapeutic intervention
  2. Tozser, J.; Oroszlan, S.
  3. Current Pharmaceutical Design. 2003 9(22): 1803-1815.
  1. 18.   Effect of sequence polymorphism and drug resistance on two HIV- 1 Gag processing sites
  2. Feher, A.; Weber, I. T.; Bagossi, P.; Boross, P.; Mahalingam, B.; Louis, J. M.; Copeland, T. D.; Torshin, I. Y.; Harrison, R. W.; Tozser, J.
  3. European Journal of Biochemistry. 2002 269(16): 4114-4120.
  1. 19.   The P1 ' specificity of tobacco etch virus protease
  2. Kapust, R. B.; Tozser, J.; Copeland, T. D.; Waugh, D. S.
  3. Biochemical and Biophysical Research Communications. 2002 294(5): 949-955.
  1. 20.   Big nidovirus genome - When count and order of domains matter
  2. Gorbalenya, A. E.
  3. Nidoviruses (Coronaviruses and Arteriviruses). 2001; 494 : 1-17.
  1. 21.   Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency
  2. Kapust, R. B.; Tozser, J.; Fox, J. D.; Anderson, D. E.; Cherry, S.; Copeland, T. D.; Waugh, D. S.
  3. Protein Engineering. 2001 14(12): 993-1000.
  1. 22.   Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases
  2. Tozser, J.; Zahuczky, G.; Bagossi, P.; Louis, J. M.; Copeland, T. D.; Oroszlan, S.; Harrison, R. W.; Weber, I. T.
  3. European Journal of Biochemistry. 2000 267(20): 6287-6295.
  1. 23.   Virus-encoded proteinases and proteolytic processing in the Nidovirales
  2. Ziebuhr, J.; Snijder, E. J.; Gorbalenya, A. E.
  3. Journal of General Virology. 2000 81(Part 4): 853-879.
  1. 24.   A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold
  2. Herold, J.; Siddell, S. G.; Gorbalenya, A. E.
  3. Journal of Biological Chemistry. 1999 274(21): 14918-14925.
  1. 25.   Effect of substrate residues on the P2 ' preference of retroviral proteinases
  2. Boross, P.; Bagossi, P.; Copeland, T. D.; Oroszlan, S.; Louis, J. M.; Tozser, J.
  3. European Journal of Biochemistry. 1999 264(3): 921-929.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel